Summary
Administration of drugs by the sublingual route provides rapid systemic absorption and avoids first-pass metabolism. The purpose of the present study was to assess the pharmacokinetics, efficacy and adverse effects of standard salbutamol tablets given by this route to patients with asthma. Seven asthmatic patients were given either sublingual salbutamol tablet 2 mg (SL), swallowed tablet 2 mg (O), metered dose inhaler 200 µg (MDI) or placebo (PL), in a randomized single-blind cross-over design. Airways responses (FEV1, FVC, PEFR), finger tremor (Tr), heart rate (HR), plasma potassium (K) and plasma salbutamol were measured over a 6 h period following drug administration.
There were highly significant changes in FEV1 with MDI, O and SL routes compared with PL, although the response to MDI was greater and more rapid than with O or SL. There were similar findings for FVC and PEFR responses. There were no adverse effects with MDI, whereas both 0 and SL produced significant tremor responses. There were no differences between O and SL for any of the pharmacodynamic parameters. In addition, pharmacokinetic profiles for O and SL were also similar apart from an initial delay in absorption with SL. There were however, no significant differences in any of the pharmacokinetic parameters, between O and SL.
This suggests that buccal absorption of salbutamol was negligible, and that systemic absorption occurred after swallowing of the dissolved sublingual tablet. These results show that sublingual administration of salbutamol tablet has no clinical benefit over the oral route.
Similar content being viewed by others
References
Walker SR, Evans ME, Richards AJ, Paterson JW (1972) The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther 13: 861–867
Morgan DJ, Paull JD, Richmond BH, Wilson-Evered E, Ziccone SP (1986) Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol 22: 587–593
Goldstein DA, Tan YK, Soldin SJ (1987) Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers. Eur J Clin Pharmacol 32: 631–634
American Thoracic Society (1987) Standardisation of spirometry — 1987 update. Am Rev Respir Dis 136: 1285–1298
Hutchings MJ, Paull JD, Morgan DJ (1983) Determination of salbutamol in plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 277: 423–426
Nie NH, Hull CH, Jenkins JG, Steinbrumer K, Bent DH (1975) SPSS: Statistical package for the social sciences, 2nd edn. McGraw-Hill, New York
Brown RD, Manno JE (1987) ESTRIP, a basic computer programme for obtaining initial polyexponential parameter estimates. J Pharm Sci 67: 1687–1691
Schuman S, Herxheimer H (1971) The bronchodilator action of salbutamol in asthmatics. Postgrad Med J 47 [Suppl]: 92–99
Rodenstein D, Stanescu DC (1982) Mouth spraying versus inhalation of fenoterol aerosol in healthy subjects and asthmatic patients. Br J Dis Chest 76: 365–373
Ruffin RE, Montgomery JM, Newhouse MT (1978) Site of beta-adrenergic receptors in the respiratory tract: Use of fenoterol administered by two methods. Chest 74: 256–260
Martin AJ, Erben A, Landau LI, Phelan PD (1976) Assessment of buccal mucosa administration of salbutamol aerosol. In: Shaw DT (ed) Recent advances in aerosol science. John Wiley, London, pp 113–116
Collier JG, Dobbs RJ, William I (1980) Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol 9: 273–274
Kung M, Croley SW, Phillips BA (1987) Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol: influence of mouth rinsing and gargling. Chest 91: 382–387
Wade A (1980) Drug absorption. In: Pharmaceutical handbook. 19th edn. The Pharmaceutical Press, London, pp 307–308
Ohashi K, Turner P (1980) Buccal absorption characteristics of some selective and non-selective beta-adrenoceptor agonists and antagonists. Br J Clin Pharmacol 9: 120 p
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lipworth, B.J., Clark, R.A., Dhillon, D.P. et al. Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in Patients with asthma. Eur J Clin Pharmacol 37, 567–571 (1989). https://doi.org/10.1007/BF00562546
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562546